| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP & Chief Financial Officer
3 companies
Mark G Foletta is Director at DXCM, with reported holdings spanning 3 companies. From April 2016 to August 2026, the filings on record show 3 open-market purchases and 28 sales. Mark G Foletta's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $6.0M at current prices.
Our model assigns Mark G Foletta a strong insider score of 70/100, based on 15 past trades. Over a 12-month horizon, 75.0% of those trades were profitable, with an average 12-month return of +13.4%.
Mark G Foletta's largest disclosed position is in DXCM as Director, worth about $4.1M. The DXCM filings lean toward selling, a net 35,750 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2016 | AMN Amn Healthcare Services Inc | Director | Sell | 1,800 | $37.81 | $68,058.00 | -32.5% |